All Innovation News articles – Page 26
-
NewsNew vaccine effective against coronaviruses that haven’t even emerged yet
Researchers have developed a new vaccine technology that has been shown in mice to provide protection against a broad range of coronaviruses with potential for future disease outbreaks - including ones we don’t even know about.
-
NewsNano-drugs hitching a ride on bacteria could help target hard-to-reach pancreatic cancer
Employing bacteria to infiltrate the dense matrix of collagen and other tissues surrounding pancreatic tumors and deliver drugs could aid treatment for pancreatic cancer.
-
NewsDiagnostic assay could identify AMR infections within hours
New research being presented at the Letters in Applied Microbiology ECS Symposium this May reveals how a new assay could potentially diagnose antimicrobial resistant infections within a matter of hours.
-
NewsResearchers produce guidelines to tackle science’s ‘AI problem’
With growing evidence revealing deep flaws in how machine learning is used in science, an interdisciplinary team of 19 researchers has published guidelines for the responsible use of AI in science.
-
NewsMarriage of synthetic biology and 3D printing produces programmable living materials
Researchers have 3D printed a bioink containing plant cells that were then genetically modified, producing programmable materials. Applications could someday include biomanufacturing and sustainable construction.
-
NewsBiomarker method targets food fraud in high-priced truffles
Two scientists have developed a new method of analysis to distinguish between high-priced Piedmont truffles and cheaper spring truffles.
-
NewsGroundbreaking clinical trial evaluates oncolytic virus for non-small cell lung cancer
Moffitt Cancer Center has launched a pioneering clinical trial for patients with late-stage non-small cell lung cancer, using a novel oncolytic virus, MEM-288, in combination with the immune checkpoint inhibitor nivolumab.
-
NewsPioneering oral fungal infection treatment shows promise in preclinical trials
A novel oral amphotericin B (MAT2203) developed for treatment of invasive mucormycosis (IM) and other deadly invasive fungal infections, has demonstrated encouraging results in a series of preclinical studies.
-
NewsBiodegradable ‘living plastic’ houses bacterial spores that help it break down
Researchers have developed a biodegradable form of thermoplastic polyurethane (TPU), filled with bacterial spores that, when exposed to nutrients present in compost, germinate and break down the material at the end of its life cycle.
-
NewsNew tool helps identify babies at high risk for RSV
A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April).
-
NewsScientists replace fishmeal in aquaculture with microbial protein from soybean processing wastewater
Scientists have successfully replaced half the fishmeal protein in the diets of farmed Asian seabass with a ‘single cell protein’ cultivated from microbes in soybean processing wastewater, paving the way for more sustainable fish farming.
-
NewsExperts developing way to harness Nobel Prize winning CRISPR technology to deal with antimicrobial resistance (AMR)
Scientists show how the latest CRISPR-Cas gene editing technology can be used to help modify and attack AMR bacteria.
-
NewsExperimental NIH malaria monoclonal antibody protective in Malian children
One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country’s six-month malaria season, according to the results of a mid-stage clinical trial.
-
NewsSynthetic droplets cause a stir in the primordial soup
A synthetic droplet may give researchers clues on how the simplest forms of life on the planet could navigate their surroundings.
-
NewsStudy finds artificial intelligence can develop treatments to prevent superbugs
Researchers developed an AI model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on how quickly the bacteria grow given certain perturbations.
-
NewsVaccine candidate could fight antibiotic resistance
Scientists have announced several discoveries that will help the development of a carbohydrate-based vaccine for infections caused by Staphylococcus aureus and its “superbug” relative methicillin-resistant Staphylococcus aureus, or MRSA.
-
NewsLivestock abortion surveillance could protect livelihoods and detect emerging global pathogens
A study suggests timely reporting and investigating of livestock abortions is feasible in rural areas and can provide insights into emerging infectious diseases.
-
NewsEngineers muffle invading pathogens with a ‘molecular mask’
Researchers are developing a hydrogel therapy that acts as a first line of defense against viruses and other biological threats. The peptides that make up this gel prevent viruses such as SARS-CoV-2 from attaching to and entering cells.
-
NewsPromising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
The new molecule has the potential to revolutionize treatment for the deeply neglected and hard-to-treat disease, as the Eastern Africa region charts the way to its elimination.
-
NewsGold may be key element for cleaner drinking water
Researchers are exploring the use of gold to develop a novel method to rid drinking water of harmful algal blooms, or HABs, which occur when colonies of algae grow out of control and produce toxic or harmful effects on living creatures.